Breaking the sound barrier: global monoclonal antibody pharmacoequity
Monoclonal antibodies represent one of biomedicine's greatest successes, yet global access remains profoundly inequitable, with low- and middle-income countries bearing the brunt of limited access. This perspective proposes that long-acting infectious disease mAbs, starting with WHO-recommended nirs...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2026-06-01
|
| Seri Bilgileri: | Frontiers in Pediatrics |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fped.2026.1845146/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|